CEP
ARNA

Chicago Equity Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Chicago Equity Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,020
Closed -$410K – 922
2019
Q4 		$410K Sell
9,020
-6,585
-42% -$311K 0.02% 682
2019
Q3 		$714K Buy
+15,605
New +$877K 0.03% 591

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Chicago Equity Partners's ARNA Position: Q1 2020 in Review

Chicago Equity Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 9,020 shares — an estimated $410K sold.

Chicago Equity Partners first reported a position in ARNA in Q3 2019 and held it in 2 quarters. The position peaked at $714K in Q3 2019. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • Chicago Equity Partners reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 9,020 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $410K.
  • Chicago Equity Partners first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 2 quarters.
  • Chicago Equity Partners's Arena Pharmaceuticals Inc position peaked at $714K in Q3 2019.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.